- Trials with a EudraCT protocol (120)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (7)
120 result(s) found for: Antimicrobial therapy.
Displaying page 1 of 6.
EudraCT Number: 2016-004447-36 | Sponsor Protocol Number: ZonMw848015005 | Start Date*: 2017-06-23 |
Sponsor Name:Stichting Rotterdams Onderzoeksconsortium Kindergeneeskunde | ||
Full Title: INTRAVENOUS-TO-ORAL ANTIBIOTIC SWITCH THERAPY FOR SUSPECTED NEONATAL BACTERIAL INFECTIONS: CLINICAL EFFICACY, SAFETY AND COST-EFFECTIVENESS | ||
Medical condition: Neonatal probable bacterial infection | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-001376-73 | Sponsor Protocol Number: INN-TOP-003 | Start Date*: 2008-12-16 | |||||||||||
Sponsor Name:Innocoll Technologies | |||||||||||||
Full Title: A Randomized, Controlled, Open-Label Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge (Collatamp® G) in Combination With Antimicrobial Therapy Compared to Antimi... | |||||||||||||
Medical condition: Diabetic patients with a moderate infection of a lower extremity skin ulcer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001363-58 | Sponsor Protocol Number: PPAPR0202 | Start Date*: 2006-11-14 |
Sponsor Name:Photopharmica Ltd | ||
Full Title: Phase IIa randomised, placebo controlled trial to investiagte antimicrobial photodynamic therapy in chronic leg ulcers and diabetic foot ulcers. | ||
Medical condition: Chronic leg ulcers and chronic diabetic foot ulcers | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-005079-90 | Sponsor Protocol Number: PPA/904W/003 | Start Date*: 2008-12-18 | |||||||||||
Sponsor Name:Photopharmica Ltd | |||||||||||||
Full Title: Phase II randomised, placebo controlled trial to investigate repeat dose antimicrobial photodynamic therapy in patients with chronic leg ulcers | |||||||||||||
Medical condition: Chronic leg ulcers | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002532-16 | Sponsor Protocol Number: 02 | Start Date*: 2017-12-05 |
Sponsor Name:Cliniques Universitaires Saint-Luc | ||
Full Title: Adjunctive systemic antimicrobial therapy in the surgical treatment of peri-implantitis. A prospective randomized clinical study | ||
Medical condition: To treat patients with chronic infection of dental implants. One group with antibiotics and one group without. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-004333-42 | Sponsor Protocol Number: SISPCT | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Friedrich-Schiller-University of Jena | |||||||||||||
Full Title: Prospective randomized clinical multicenter trial about the effect of an adjunctive intravenous treatment with sodium selenite (selenase®T, double-blind) and a procalcitonin guided causal therapy (... | |||||||||||||
Medical condition: severe sepsis / septic shock | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002197-78 | Sponsor Protocol Number: APHP200011 | Start Date*: 2021-08-19 |
Sponsor Name:Assistance Publique - Hôpitaux de Paris | ||
Full Title: Antimicrobial Stewardship For Ventilator Associated Pneumonia in Intensive Care Acronym: ASPIC | ||
Medical condition: ventilator associated neumonia in intensive care | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2008-000036-41 | Sponsor Protocol Number: IPTG-01 | Start Date*: 2014-04-08 | |||||||||||
Sponsor Name:Dermal Laboratories Ltd | |||||||||||||
Full Title: An antimicrobial cream for the treatment of impetigo | |||||||||||||
Medical condition: The condition to be studied is uncomplicated localised primary non-bullous impetigo, suitable for topical antibacterial therapy alone. | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002148-95 | Sponsor Protocol Number: SHORTEN | Start Date*: 2014-05-21 | |||||||||||
Sponsor Name:Fundación Pública Andaluza para la Gestión en Salud de Sevilla (FISEVI) | |||||||||||||
Full Title: Optimal duration of the antimicribial treatment for bloodstream infections produced by Enterobacteriaceae. Clinical trial "SHORTEN". | |||||||||||||
Medical condition: Adult patients with bloodstream infections produced by Enterobacteriaceae. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003931-30 | Sponsor Protocol Number: CBS-EAM-10d | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Hôpital Universitaire Des Enfants Reine Fabiola | |||||||||||||
Full Title: A prospective open-label study on efficacy and tolerability of colloidal bismuth sub-citrate as adjunctive therapy to a combination of esomeprazole, amoxicillin and metronidazole for 10 days for He... | |||||||||||||
Medical condition: Helicobacter pylory infection | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004211-30 | Sponsor Protocol Number: 2005-23 | Start Date*: 2005-10-17 |
Sponsor Name:The Norwegian Radium Hospital | ||
Full Title: Penicillin G and an aminoglycoside versus meropenem as initial empiric antibiotic therapy in lymphoma and leukemia patients with febrile neutropenia | ||
Medical condition: Lymphoma and leukemia patients with febrile neutropenia | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000136-17 | Sponsor Protocol Number: Target_ZKSJ0085 | Start Date*: 2016-08-22 |
Sponsor Name:Friedrich Schiller University Jena | ||
Full Title: Prospective, randomized, multicenter clinical trial on the impact of Therapeutic Drug Monitoring (TDM) of piperacillin on organ functions and survival in the treatment of severe sepsis or septic shock | ||
Medical condition: Patients with a severe sepsis oder a septic shock treatet with piperacillin/tazobactam | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-001396-16 | Sponsor Protocol Number: OP0595-6 | Start Date*: 2023-03-29 | |||||||||||||||||||||||||||||||
Sponsor Name:Meiji Seika Pharma Co., Ltd. | |||||||||||||||||||||||||||||||||
Full Title: A Phase 3, Multi-Center, Randomized, Single-Blind Study to Assess the Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy in Adults With Complicated Ur... | |||||||||||||||||||||||||||||||||
Medical condition: Complicated urinary tract infection (cUTI), acute uncomplicated pyelonephritis (AP), hospital acquired bacterial pneumonia (HABP), ventilator-associated bacterial pneumonia (VABP), and complicated ... | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: FR (Trial now transitioned) SK (Trial now transitioned) GR (Trial now transitioned) LV (Trial now transitioned) ES (Ongoing) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001376-38 | Sponsor Protocol Number: LOCKIA | Start Date*: 2019-08-13 |
Sponsor Name:María Dolores Sousa Regueiro | ||
Full Title: Antimicrobials Local Administration for Intraabdominal Abscesses Treatment: Controlled, Randomized, Open, Parallel Groups, Clinical Trial | ||
Medical condition: Intra-abdominal abscesses | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-007640-10 | Sponsor Protocol Number: J&P002/2007 | Start Date*: 2009-01-28 |
Sponsor Name:PD Dr. med. K-H. Konz | ||
Full Title: Tissue pharmacokinetics of daptomycin measured by in vivo microdialysis in patients with diabetic foot infection | ||
Medical condition: A group of adult male or female patients with documented diabetes and bacterial soft tissue infection of the foot who must be subjected to undergo intravenous antimicrobial therapy with broad-spect... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-006153-41 | Sponsor Protocol Number: J&P004/2008 | Start Date*: 2009-03-30 |
Sponsor Name:Medical university Graz, Department of Plastic Surgery | ||
Full Title: Target site pharmacokinetics of linezolid after repetitive doses in diabetic patients with bacterial foot infection | ||
Medical condition: The study population will consist of a representative group of adult male or female patients with documented diabetes and bacterial soft tissue infection of the foot complicated by osteomyelitis. P... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-006949-75 | Sponsor Protocol Number: J&P005/2008 | Start Date*: 2009-08-13 |
Sponsor Name:Medical University Graz, Department for Plastic Surgery | ||
Full Title: Tissue pharmacokinetics of daptomycin measured by in vivo microdialysis in patients with diabetic foot infection | ||
Medical condition: A group of adult male or female patients with documented diabetes and bacterial soft tissue infection of the foot who must be subjected to undergo intravenous antimicrobial therapy with broad spect... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-001855-37 | Sponsor Protocol Number: OCT02-2006 | Start Date*: 2007-05-14 | |||||||||||
Sponsor Name:Schülke & Mayr GmbH | |||||||||||||
Full Title: Effect of an octenidine-based topical antimicrobial agent (Octenisept) on wound healing of chronic venous leg ulcers: a prospective, twelve-week comparison versus local treatment with Ringer soluti... | |||||||||||||
Medical condition: Chronic venous leg ulcers In Germany, approximately three million people suffer from chronic leg ulcers of various origins. These ulcers are often very painful and extremely cost-intensive disease... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) FR (Completed) HU (Prematurely Ended) GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004037-10 | Sponsor Protocol Number: CE01-119 | Start Date*: 2014-10-10 |
Sponsor Name:Cempra Pharmaceuticals, Inc. | ||
Full Title: A phase 1, open-label, multi-centre study to determine the PK and safety of a 5-day oral dosing of solithromycin as add-on therapy to antimicrobial agent administered to adolescent with suspected o... | ||
Medical condition: suspected or confirmed bacterial infection | ||
Disease: | ||
Population Age: Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2011-000064-10 | Sponsor Protocol Number: Fistula-SD-MD | Start Date*: 2011-03-17 |
Sponsor Name:Med. Univ. Wien, Klinik für klinische Pharmakologie | ||
Full Title: Target site pharmacokinetics of linezolid or tigecycline in patients with severe skin and skin structure infections (SSSI) associated with chronic fistulas. | ||
Medical condition: The findings of the present study will enable assessing whether currently employed therapy regimens with linezolid or tigecycline provide effective antimicrobial concentrations at the target site o... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
